GB1191965A — Betamethasone 17-Benzoate
Assigned to Warner Lambert Co LLC · Expires 1970-05-13 · 56y expired
What this patent protects
1,191,965. Anti - inflammatory medicines. WARNER-LAMBERT PHARMACEUTICAL CO. 29 Feb., 1968 [1 March, 1967], No. 9842/ 68. Heading A5B. [Also in Division .C2] Anti-inflammatory compositions comprise the steroid betamethosone 17-benzoate (i.e. 17α-benzoyloxy-9α-fluoro-16#-methyl-pre…
USPTO Abstract
1,191,965. Anti - inflammatory medicines. WARNER-LAMBERT PHARMACEUTICAL CO. 29 Feb., 1968 [1 March, 1967], No. 9842/ 68. Heading A5B. [Also in Division .C2] Anti-inflammatory compositions comprise the steroid betamethosone 17-benzoate (i.e. 17α-benzoyloxy-9α-fluoro-16#-methyl-pregna- 1,4-diene-11#, 21-diol-3, 20-dione) together with a pharrnaceutcial carrier or excipient. The compositions may in addition include antibiotics (e.g. neomycin sulphate, colistin sulphate, bacitracin, chloramphenicol), local anesthetics or sulphonamides, as well as preservative or bacteriostatic agents, stabilising, thickening and colouring agents and perfumes. The compositions may be administered orally, rectally, or topically.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.